Related by context. Frequent words. (Click for all words.) 62 liposomal formulation 62 TLR9 agonist 61 subcutaneous formulation 61 Phase Ib II 61 Panzem R 60 Shigamabs ® 60 elotuzumab 60 Urocidin 60 therapeutic monoclonal antibodies 60 multi kinase inhibitor 60 phase IIa clinical 59 IMC #B 59 Phase 2b clinical trials 59 anticancer compound 58 Nexavar ® 58 Phase Ib clinical 58 ALN TTR# 58 PEG SN# 58 humanized anti 58 phase IIb 58 deforolimus 58 registrational 58 Phase 1b clinical 58 Rebif ® 57 confirmatory Phase III 57 atacicept 57 mTOR inhibitor 57 Initiate Phase 57 phase IIb clinical 57 amrubicin 57 Factor VIIa 57 TOCOSOL Paclitaxel 57 Aerosurf 57 ATL# [001] 57 outlicensing 57 HCV protease inhibitor 57 Phase IIb trials 56 OncoVEX GM CSF 56 Cetrorelix 56 Nanobody 56 Hepatitis C HCV 56 phase IIa 56 ATHX 56 Phase IIa clinical 56 Eligard R 56 EOquin 56 liprotamase 56 Daclizumab 56 epothilone 56 eprotirome 56 PREOS 55 Recombinant Human 55 Phase 2b clinical 55 Bicifadine 55 Aloxi R 55 Onalta 55 Aurora kinase 55 Pivotal Phase III 55 CORT # 55 Idera Pharmaceuticals 55 TREANDA 55 Icatibant 55 faropenem 55 Phase 2a trial 55 Orphan Drug status 55 humanized antibody 55 Loramyc R 55 phase Ib 55 Privigen 55 WILEX 55 antisense drug 54 celgosivir 54 CRTX 54 Nasdaq ENZN 54 Phase Ib 54 hematological cancers 54 fusion inhibitor 54 Pivotal Phase 54 Guanilib 54 ACHN 54 ponatinib 54 metastatic hormone refractory 54 MEK inhibitor 54 MOZOBIL 54 polymerase inhibitor 54 NVA# 54 TH# [003] 54 FavId 54 Zalbin 54 Azedra 54 multicenter Phase 54 MORAb 54 Advicor 54 vascular disrupting agent 54 Nautilus Biotech 53 Octreotide 53 investigational compound 53 NASDAQ CRXL 53 ganetespib 53 FGFR 53 registrational trial